Search
Oct 30, 2024
The CEO of the nonprofit MassChallenge describes the way it supports startups and entrepreneurs, and why it has chosen Dallas as its second region of major focus in the U.S. outside of Boston
Cait Brumme highlights MassChallenge's equity-free model and how it helps biotech entrepreneurs from the earliest stages to understanding...
Oct 29, 2024
Biotech entrepreneur RA Session II describes converting science from UT Southwestern into companies - he currently has a new one that is in stealth mode
Having been involved with Reata, Taysha Gene Therapies (founder), ReCode Therapeutics and more, RA has a good handle on the biotech scene...
Oct 29, 2024
The CEO of LH Capital, a key supporter of the life sciences industry in North Texas, describes the progress the biotech community here has made over the last year
Nicole Small discusses events that have recently taken place like the acquisition of Reata, ARPA-H choosing Dallas for a regional center,...
Oct 29, 2024
UT Southwestern professor Philipp Scherer talks about his work focusing on adipose cells and a local biotech company, PriveBio, that has come out of it
Dr. Scherer describes the work he is doing in areas like diabetes and fibro-inflammation. Plus, PriveBio's programs focusing on...
Oct 22, 2024
Piper Sandler analyst Biren Amin discusses recent news in ATTR cardiomyopathy, ophthalmology, Duchenne muscular dystrophy, and more
Biren Amin joins BiotechTV from the NYSE and discusses BridgeBio, Ocular Therapeutix, Apellis, Sarepta, Solid Bio, Cargo Therapeutics,...
Oct 18, 2024
Backed by a conglomerate that has pharma expertise, Rome based Angelini Ventures has a $300M fund that invests broadly in life sciences and healthcare
Medical Director Fabrizio Calisti describes the fund, its foundation in the CNS but broad interest today, current portfolio holdings, and...
Oct 16, 2024
The Foundation for Innovation and Tech Transfer has consolidated business development and tech transfer for 7 institutions in northern Italy to expedite the commercialization of the area's research
Managing Director Marco Baccanti explains how the foundation was created last year to boost the amount of IP and licensing that is...
Oct 10, 2024
The co-founder of the startup Ousia Pharma describes working from Copenhagen's BioInnovation Institute on his company's next-generation enhancer to GLPs
Anders Bue Klein describes how the BI has made it easier for founders like him to take work from university and turn it into a company....
Oct 9, 2024
Biotech veteran Hans Schikan gives an overview of the Netherlands' life sciences scene
The former CEO of Prosensa and current contributor to numerous boards highlights the past and current successes that have made this region a
Oct 3, 2024
Mizuho senior analyst Graig Suvannavejh joins BiotechTV for Analyst Thursdays from Kendall Square
He shares his take on biotech and discusses Terns, Novo Nordisk, Corbus, Harmony Bio, IDEAYA, and Adverum.
Oct 3, 2024
Vedanta Biosciences founder and CEO Bernat Olle shares an expert take on microbiome drug development
He describes how Vedanta is isolating specific bacterial strains and using them as a defined composition for its medicines, and why he...
Oct 1, 2024
Biotech lab technologies expert Bob Gantzer talks about the digital lab book, rovers, and future technologies still to come in biotech
The VP of Lab Technologies at Aera Therapeutics describes what lab work was like before technology digitized and dramatically changed...
Sep 27, 2024
Innovation Day San Diego: The director of UCSD's Center for RNA Technologies and Therapeutics shares his thoughts on the RNA field
Gene Yeo describes the latest advances in RNA and discusses mRNA, RNAi, antisense, exon skipping and more.
Sep 26, 2024
Houston Oncology Summit: The Cancer Focus Fund is closing on its second fund - it's a unique model that helps companies with knowhow and trial support at MD Anderson
General Partner Ross Barrett talks about how a new, larger fund will enable them to invest in more companies, and he shares some...
Sep 26, 2024
Houston Oncology Summit: MD Anderson's Chief Data & Analytics Officer describes the impact of the digitization of medicine
As a practicing clinician, Caroline Chung became increasingly focused on digital solutions. Today, she tells us how it is impacting...
Sep 26, 2024
Houston Oncology Summit: Oppenheimer analysts Jeff Jones and Jay Olson talk radiopharmaceuticals and antibody-drug conjugates
Jeff Jones notes how radioisotopes are being added to more than just antibodies, and calls out upcoming data from Perspective...
Sep 26, 2024
Houston Oncology Summit: MD Anderson Professor of Immunology Michael Curran talks turning cold tumors hot, including work by his company ImmunoGenesis
He discusses pathways that could play a role in helping solve this problem, including combinations with ADCs, STING and CD47, and work by...
Sep 26, 2024
Houston Oncology Summit: Oppenheimer analyst Matt Biegler discusses the breast cancer space and learnings from the conference
Matt Biegler summarizes a breast cancer panel from the conference and talks about recent data from Relay and upcoming data from Gilead....
Sep 26, 2024
Houston Oncology Summit: MD Anderson's Katy Rezvani, an expert in NK cell therapies, gives an overview of what is in development in this space
She describes the properties that she believes give NK cells an edge over T-cells, and discussed work in cell therapies, engagers, and...
Sep 26, 2024
Houston Oncology Summit: MD Anderson's John Heymach, a leading expert in lung cancer, talks about the latest in TKI's, KRAS, Bi-specifics, and more
John Heymach gives an overview of how TKIs are progressing in the EGFR and HER2 space, his thoughts on the recent VEGF x PD1 data that...
.png){kind=logo}
